Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Return on Sales: 2020-2024

Historic Return on Sales for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to 0.16%.

  • Oncology Institute's Return on Sales rose 400.0% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.16% for FY2024, which is 900.0% up from last year.
  • Per Oncology Institute's latest filing, its Return on Sales stood at 0.16% for FY2024, which was up 900.0% from 0.26% recorded in FY2023.
  • In the past 5 years, Oncology Institute's Return on Sales ranged from a high of 0.0% in FY2022 and a low of 0.26% during FY2023
  • Its 5-year average for Return on Sales is 0.11%, with a median of 0.08% in 2020.
  • In the last 5 years, Oncology Institute's Return on Sales plummeted by -2600bps in 2023 and then surged by 900bps in 2024.
  • Oncology Institute's Return on Sales (Annual) stood at 0.08% in 2020, then rose by 30bps to 0.05% in 2021, then surged by 101bps to 0.0% in 2022, then crashed by -42656bps to 0.26% in 2023, then surged by 36bps to 0.16% in 2024.
  • Its last three reported values are 0.16% in FY2024, 0.26% for FY2023, and 0.0% during FY2022.